InvestorsHub Logo
Followers 49
Posts 4454
Boards Moderated 0
Alias Born 03/20/2012

Re: Brandywhitneylady post# 14650

Friday, 03/17/2023 11:32:32 AM

Friday, March 17, 2023 11:32:32 AM

Post# of 14952
SAN DIEGO, March 17, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, announced that on March 16, 2023, the LA County Superior Court confirmed an arbitration award of $125 million in damages, to be paid by NantPharma, LLC ("NantPharma"). The award reflects the values of lost milestones for the approval of the drug Cynviloq® for the treatment of breast and lung cancers.